跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TEVA-TERIFLUNOMIDE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
TEVA-TERIFLUNOMIDE
Authorized
STANDARD
TEVA-TERIFLUNOMIDE
teva canada limited
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
31a7776ee9e44792
Company
teva canada limited
Type
Standard
Approval Details
Approval Id
31a7776ee9e44792
Drug Approval Canada Name
TEVA-TERIFLUNOMIDE
Product Name
TEVA-TERIFLUNOMIDE
Status
Marketed
Status Date
2022-05-16
Original Market Date
2022-05-16
Din
02501090
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
90:04.20
Atc Original
L04AK02 TERIFLUNOMIDE
Atc Name
l 04 ak 02
Aig Number
0154970001
Company Name
teva canada limited
Company Address
30 Novopharm Court, Toronto, Ontario, Canada, M1B 2K9
Active Ingredients
TERIFLUNOMIDE
14 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
31a7776ee9e44792
Type
Standard
Back to Health Canada Approvals